Log In
BCIQ
Print this Print this
 

MRB-8001, MRLS-8001

  Manage Alerts
Collapse Summary General Information
Company Mirabilis Therapeutics B.V.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHeart failure
Indication DetailsTreat heart failure with preserved ejection fraction
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today